April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Histologic Corneal Changes Following Optimal Keratoplasty (Opti-K) Treatment of Cadaver Eyes
Author Affiliations & Notes
  • Ellen H. Koo
    Division of Ophthalmology, Brown University, Warren Alpert Medical School, Providence, Rhode Island
  • Harry G. Glen
    Advanced Eye Center, Dartmouth, Massachusetts
  • Michael Berry
    NTK Enterprises, Inc., Plano, Texas
  • Paul J. Botelho
    Division of Ophthalmology, Brown University, Warren Alpert Medical School, Providence, Rhode Island
  • Footnotes
    Commercial Relationships  Ellen H. Koo, None; Harry G. Glen, NTK Enterprises, Inc (R); Michael Berry, NTK Enterprises, Inc. (C, P); Paul J. Botelho, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5789. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ellen H. Koo, Harry G. Glen, Michael Berry, Paul J. Botelho; Histologic Corneal Changes Following Optimal Keratoplasty (Opti-K) Treatment of Cadaver Eyes. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5789.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The Optimal Keratoplasty (Opti-K) system using laser thermal keratoplasty with a sapphire applanation window/ suction ring accessory (SAWSR) to protect the corneal epithelium is a novel technique to correct hyperopia. We report histologic findings in 4 cadaver eyes treated by Opti-K with and without the SAWSR.

Methods: : Four cadaver eyes from 2 human donors were obtained. One eye from the first donor received Opti-K treatment with the SAWSR at 60mJ and was labeled Human-1; the fellow eye received Opti-K treatment without the SAWSR at 59mJ and was labeled Human-2. One eye from the second donor received Opti-K treatment with the SAWSR at 59 mJ and was labeled Human-3; the fellow eye received Opti-K treatment without the SAWSR at 59 mJ and was labeled Human-4. The corneas were prepared in Hematoxylin and Eosin, Alcian Blue and Periodic acid-Schiff stain. All slides were read by the same pathologist, Nora Laver, M.D.

Results: : All eyes showed anterior stromal thermal reaction with mild involvement of Bowman’s layer and sparing of the endothelial layer. Human-1 and Human-2 demonstrate bullae formation and degeneration of the basal epithelial cells. Human-3 showed less alteration of the basal epithelial cells and a smaller upper stromal heat affected zone (HAZ) compared to Human-4. Human-4 had a larger area of HAZ with bullae formation as well as marked stromal edema. Neither of these changes was observed in Human-3.

Conclusions: : Photothermal treatment using the Opti-K device without the SAWSR resulted in large, obvious areas of laser HAZ with bullae formation and alteration of the basal epithelial cells, while the use of the Opti-K with the SAWSR resulted in a markedly smaller upper stromal HAZ as well as an absence of stromal edema and bullae formation, as demonstrated by the comparison of Human-3 and Human-4.Comparison of Human-1 and Human-2 showed equal amount of epithelial damage. It is possible that the epithelium was damaged prior to treatment, as this layer is most vulnerable to trauma during harvest and transport, and unfavorable preservation conditions. In addition, the protective properties of the SAWSR may be limited by the energy setting. Human-1 received treatment with the SAWSR at 60 mJ; at this setting, the sequelae of photothermal treatment were similar to Human-2, which received treatment without the SAWSR at 59 mJ. The protective effects of the SAWSR may be lost at settings beyond 59mJ. Further in-vivo and clinical studies are needed to study the safety and long-term efficacy of the Opti-K system.

Keywords: refractive surgery • refractive surgery: other technologies 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×